Roger von Moos
Swiss Group For Clinical Cancer Research(CH)Kantonsspital Graubünden(CH)
Publications by Year
Research Areas
Bone health and treatments, Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies, Cancer Diagnosis and Treatment, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma(2011)1,252 cited
- → Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial(2012)1,159 cited
- → The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network(2013)466 cited
- → Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer(2006)206 cited
- → Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors(2013)182 cited
- → Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study